Drug intelligence / Profile preview

Hemax

Development stage
Unknown
Lead developer
BASF
Modality
Small Molecules
Administration
Oral
01

Overview

Hemax is an oral nutritional supplement and therapeutic mineral product developed by Pronova Corp, specifically designed to treat or prevent iron deficiency and iron-deficiency anemia while mitigating the common side effect of constipation. The formulation features carbonyl iron, a highly pure form of elemental iron that is naturally regulated by the body during absorption, making it generally better tolerated and less toxic than traditional ferrous salts. To counteract the gastrointestinal distress and constipation typically associated with high-dose iron supplementation, Hemax includes docusate sodium, a surfactant that acts as a stool softener. The supplement is further enriched with Vitamin C (ascorbic acid) to enhance iron absorption, as well as essential B-vitamins including Vitamin B12 and folic acid (often provided as L-methylfolate) and minerals like copper and biotin, which serve as vital cofactors for erythropoiesis and red blood cell maturation.

Brand names
Hemax
Other names
multivitamins + minerals + folic acid + iron + docusatecarbonyl iron + docusate sodium + vitamins
02

Targets

Erythropoietin Receptor

Beyond the preview

Go deeper on Hemax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call